NCT03212755

Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy

Serum Immunoglobulin (G ) as a Predictive Marker of Early Renal Affection in Type 2 Diabetic Patients

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 75 (estimated)
• Sponsor: Assiut University · Academic / Other
• Sex: All
• Age: 30 Years – 70 Years
• Healthy volunteers: Accepted

Summary

Diabetes mellitus is a chronic disease that affects 366 million people worldwide ( 6.4 % of the adult population ) and is expected to rise to 522 million by 2030 . Diabetic nephropathy occurs in approximately one - third of all people with diabetes and is the leading cause of renal failure in developed and developing countries Diabetic nephropathy is a severe complication occurring in diabetic patients and it is associated with an increased risk of all- cause mortality , cardiovascular disease and progression to end stage renal disease , requiring costly renal replacement therapy in the form of dialysis or transplantation

Conditions

• Diabetic Nephropathies

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	serum immunoglobulin G level	measurement of the serum level as a marker of diabetic complications

Timeline

• Start date: 2017-08-01
• Primary completion: 2019-06-01
• Completion: 2019-12-01
• First posted: 2017-07-11
• Last updated: 2017-07-11